enVVeno Medical (NVNO) Institutional Ownership $0.78 -0.03 (-3.79%) Closing price 04:00 PM EasternExtended Trading$0.80 +0.02 (+2.54%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for enVVeno Medical (NASDAQ:NVNO)CurrentInstitutional OwnershipPercentage34.71%Number ofInstitutional Buyers(last 12 months)19TotalInstitutional Inflows(last 12 months)$9.65MNumber ofInstitutional Sellers(last 12 months)7TotalInstitutional Outflows(last 12 months)$1.59M Get NVNO Insider Trade Alerts Want to know when executives and insiders are buying or selling enVVeno Medical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NVNO Institutional Buying and Selling by Quarter enVVeno Medical Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Perceptive Advisors LLC1,284,966$5.13M0.5%N/A6.675% 8/14/2025 Jane Street Group LLC12,833$51K0.0%N/A0.067% 8/14/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC 241,161$962K0.0%-18.5%1.253% 8/12/2025 XTX Topco Ltd17,627$70K0.0%-42.1%0.092% 8/12/2025 JPMorgan Chase & Co.182,300$727K0.0%-6.1%0.947% 8/11/2025 Universal Beteiligungs und Servicegesellschaft mbH200,000$798K0.0%N/A1.039% 8/8/2025 Creative Planning13,500$54K0.0%N/A0.070% 8/8/2025 Geode Capital Management LLC199,509$796K0.0%+1.1%1.036% 8/5/2025 Westside Investment Management Inc.279,525$1.12M0.2%+7.9%1.594% 5/13/2025 Altium Capital Management LLC123,256$324K0.8%-60.2%0.703% Get the Latest News and Ratings for NVNO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for enVVeno Medical and its competitors with MarketBeat's FREE daily newsletter. 5/8/2025 XTX Topco Ltd30,437$80K0.0%N/A0.174% 5/7/2025 Dauntless Investment Group LLC70,848$186K0.2%N/A0.404% 5/2/2025 Hohimer Wealth Management LLC20,000$53K0.0%-61.0%0.114% 4/25/2025 Westside Investment Management Inc.259,050$681K0.1%+26.4%1.477% 2/17/2025 Alyeska Investment Group L.P.209,180$632K0.0%-50.8%1.193% 2/14/2025 Jane Street Group LLC18,502$56K0.0%N/A0.105% 2/14/2025 Northern Trust Corp56,725$171K0.0%+68.3%0.323% 2/14/2025 Dimensional Fund Advisors LP16,242$49K0.0%-51.1%0.093% 2/14/2025 Altium Capital Management LLC310,000$936K0.3%+29.8%1.767% 2/13/2025 Marshall Wace LLP48,818$147K0.0%N/A0.278% 2/12/2025 Geode Capital Management LLC181,737$549K0.0%+20.6%1.036% 2/12/2025 National Bank of Canada FI20,000$60K0.0%N/A0.114% 2/12/2025 JPMorgan Chase & Co.270,041$816K0.0%N/A1.540% 2/11/2025 Virtu Financial LLC28,533$86K0.0%N/A0.163% 1/31/2025Sanctuary Advisors LLC12,000$39K0.0%N/A0.068% 1/17/2025 Westside Investment Management Inc.205,025$619K0.1%+132.0%1.169% 1/15/2025 Fermata Advisors LLC35,706$108K0.0%+18.1%0.204% 11/20/2024 Westside Investment Management Inc.88,375$297K0.1%+128.0%0.504% 11/19/2024 Hohimer Wealth Management LLC85,000$286K0.1%N/A0.485% 11/16/2024 Geode Capital Management LLC150,676$506K0.0%+7.8%0.859% 11/15/2024 Maven Securities LTD87,880$295K0.0%N/A0.501% 11/14/2024 Corsair Capital Management L.P.116,000$390K0.1%N/A0.661% 8/20/2024 Nantahala Capital Management LLC477,855$2.51M0.1%-3.6%3.585% 7/17/2024 Westside Investment Management Inc.38,762$204K0.0%+933.7%0.291% 7/13/2024 Fermata Advisors LLC30,949$162K0.0%+33.4%0.232% 5/16/2024 Kingdon Capital Management L.L.C.653,870$3.56M0.4%+5.6%4.905% 5/15/2024 Quadrature Capital Ltd18,872$103K0.0%N/A0.142% 5/10/2024 Acadian Asset Management LLC6,825$37K0.0%N/A0.051% 5/10/2024 Vanguard Group Inc.573,955$3.12M0.0%+70.6%4.310% 5/3/2024 RIA Advisory Group LLC43,666$238K0.1%N/A0.328% An $8 trillion-dollar discovery 17,000 ft underwater (Ad)A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.See the name and ticker behind America’s $16 trillion resource push.5/1/2024 Janney Montgomery Scott LLC34,140$186K0.0%N/A0.256% 4/12/2024 Fermata Advisors LLC23,198$126K0.0%+42.1%0.174% 3/18/2024 Kingdon Capital Management L.L.C.619,180$3.18M0.4%+182.5%4.648% 2/26/2024 Perceptive Advisors LLC623,315$3.20M0.1%-20.3%4.680% 2/13/2024 Armistice Capital LLC436,000$2.24M0.0%N/A3.273% 1/19/2024 Fermata Advisors LLC16,325$84K0.0%+37.8%0.123% 11/7/2023 Fermata Advisors LLC11,850$64K0.0%N/A0.089% 7/19/2023 Arthur M. Cohen & Associates LLC14,000$43K0.0%-41.7%0.148% 11/14/2022 UBS Oconnor LLC149,720$940K0.0%+26.8%1.581% 7/26/2022 Sepio Capital LP10,800$41K0.0%N/A0.114% 7/18/2022 Arthur M. Cohen & Associates LLC24,000$91K0.0%+60.0%0.253% 5/11/2022ACT Capital Management LLC401,200$2.56M2.7%+52.8%4.237% 2/15/2022 Kingdon Capital Management L.L.C.219,180$1.44M0.2%N/A2.315% 2/14/2022 Perceptive Advisors LLC781,615$5.15M0.1%N/A8.255% 2/3/2022ACT Capital Management LLC262,500$1.73M1.3%N/A2.772% 1/24/2022 Arthur M. Cohen & Associates LLC14,000$92K0.0%N/A0.148% 8/17/2021 Worth Venture Partners LLC82,886$569K0.2%-17.7%0.974% 8/16/2021 State Street Corp20,200$139K0.0%N/A0.237% 8/13/2021 Geode Capital Management LLC63,753$437K0.0%+75.8%0.749% 8/13/2021 Vanguard Group Inc.258,680$1.78M0.0%+483.6%3.038% 8/12/2021 AIGH Capital Management LLC346,885$2.38M0.4%-19.1%4.074% (Data available from 1/1/2016 forward) NVNO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVNO shares? During the previous two years, 30 institutional investors and hedge funds held shares of enVVeno Medical. The most heavily invested institutionals were Perceptive Advisors LLC ($5.13M), Kingdon Capital Management L.L.C. ($3.56M), Vanguard Group Inc. ($3.12M), Nantahala Capital Management LLC ($2.51M), Armistice Capital LLC ($2.24M), Westside Investment Management Inc. ($1.12M), and OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($962K).Learn more on enVVeno Medical's institutional investors. What percentage of enVVeno Medical's stock is owned by institutional investors? 34.71% of enVVeno Medical's stock is owned by institutional investors. Learn more on NVNO's institutional investor holdings. Which institutional investors have been buying enVVeno Medical's stock? Of the 26 institutional investors that purchased enVVeno Medical's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Perceptive Advisors LLC ($1.28M), Armistice Capital LLC ($436K), Kingdon Capital Management L.L.C. ($434.69K), Westside Investment Management Inc. ($275.78K), JPMorgan Chase & Co. ($270.04K), Vanguard Group Inc. ($237.55K), and Universal Beteiligungs und Servicegesellschaft mbH ($200K). How much institutional buying is happening at enVVeno Medical? Institutional investors have bought a total of 2,683,885 shares in the last 24 months. This purchase volume represents approximately $9.65M in transactions. Which of enVVeno Medical's major shareholders have been selling company stock? The following institutional investors have sold enVVeno Medical stock in the last 24 months: Alyeska Investment Group L.P. ($215.82K), Altium Capital Management LLC ($186.74K), OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC ($54.87K), Hohimer Wealth Management LLC ($31.30K), Dimensional Fund Advisors LP ($16.95K), XTX Topco Ltd ($12.81K), and JPMorgan Chase & Co. ($11.91K). How much institutional selling is happening at enVVeno Medical? Institutional investors have sold a total of 530,408 shares in the last 24 months. This volume of shares sold represents approximately $1.59M in transactions. Related Companies CTSO Major Shareholders ICCM Major Shareholders EDAP Major Shareholders CTCX Major Shareholders MDAI Major Shareholders PYPD Major Shareholders SRTS Major Shareholders DXR Major Shareholders APT Major Shareholders SURG Major Shareholders This page (NASDAQ:NVNO) was last updated on 9/3/2025 by MarketBeat.com Staff From Our PartnersHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredThe Orphaned Well Crisis Hidden Across AmericaAcross the U.S., millions of abandoned oil and gas wells are leaking methane into the air — a costly and dange...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.